Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

The Ras Gene02:38

The Ras Gene

7.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

9.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

5.6K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.6K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

6.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.7K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Restoring Zinc Homeostasis via a Bimetallic Nanozyme to Amplify Ferroptosis and Antitumor Immunity for Prostate Cancer Treatment.

Biomaterials research·2026
Same author

LncRNA CASC15-EZH2 Interaction Promotes Ischemia-Reperfusion Induced Acute Kidney Injury via Regulating SALL1 and Wnt/β-Catenin Pathway.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Computed tomography-ultrasonography (US) fusion for percutaneous nephrolithotomy access versus conventional US: A multicentre randomised trial.

BJU international·2026
Same author

CRLF1 Drives Prostate Cancer Progression via COMP-Mediated Activation of the FAK/PI3K/AKT Signaling Pathway.

Cancers·2026
Same author

ADAMTS2 drives prostate cancer progression by activating FAK/PI3K/AKT signaling and suppressing ferroptosis via COL1A1.

Frontiers in oncology·2026
Same author

F2R Promotes Prostate Cancer Progression via COL8A1-Dependent Activation of the FAK/PI3K/AKT Signaling Axis.

The journal of gene medicine·2026

相关实验视频

Updated: Mar 12, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

13.1K

通过RAC1-依赖RAS/MAPK激活,CSDE1驱动葡萄糖分解和前列腺癌的进展.

Zhen Yin1, Zefeng Wang1, Wei Gong1

  • 1Department of Urology, Renmin Hospital of Wuhan University, Wuhan, China.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
|March 11, 2026
PubMed
概括

该研究发现,CSDE1通过增强RAC1信号传递和新陈代谢来促进前列腺癌 (PCa) 的生长. 降低CSDE1水平可能为PCa患者提供新的治疗策略.

关键词:
CSDE1 关于我们的生活在RAC1中,RAC1是指RAC1.这是RAS/MAPK.生物标志物生物标志物葡萄糖溶解是什么前列腺癌是前列腺癌.

更多相关视频

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

3.4K
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.5K

相关实验视频

Last Updated: Mar 12, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

13.1K
Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

3.4K
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.5K

科学领域:

  • 在瘤学瘤学.
  • 分子生物学分子生物学
  • 癌症研究 癌症研究

背景情况:

  • 前列腺癌 (PCa) 是男性癌症死亡的主要原因.
  • 确定PCa进展的分子驱动因素对于开发新疗法至关重要.

研究的目的:

  • 研究CSDE1在前列腺癌进展中的作用.
  • 阐明CSDE1在PCa中的功能背后的分子机制.

主要方法:

  • 对PCa组织中CSDE1表达的分析.
  • 在体外研究涉及CSDE1在PCa细胞中的敲击.
  • 细胞增殖,迁移,入侵和代谢活动的评估 (ECAR,OCR,乳酸).
  • 研究CSDE1与RAC1,MAPK信号,GLUT1和LDHA的关联.
  • 在体内瘤生长模型.

主要成果:

  • CSDE1在PCa上升调节,并且与高格里森得分患者的生存率较差有关.
  • CSDE1 knockdown 抑制了PCa细胞的增殖,迁移,入侵,并抑制了代谢活动.
  • CSDE1表达与RAC1,MAPK路径改变,GLUT1和LDHA相关联.
  • 在体内验证,CSDE1-RAC1轴促进瘤生长.

结论:

  • CSDE1通过激活RAC1介导的MAPK信号和改变细胞代谢来驱动PCa的进展.
  • CSDE1代表了前列腺癌的潜在预后生物标志物和治疗点.